Innovator IBD 50 ETF (FFTY)

NYSEARCA: FFTY · Real-Time Price · USD
33.98
-0.20 (-0.59%)
At close: Apr 7, 2026, 4:00 PM
35.87
+1.89 (5.56%)
Pre-market: Apr 8, 2026, 7:45 AM EDT
Assets$78.76M
Expense Ratio0.80%
PE Ratio35.18
Shares Out2.30M
Dividend (ttm)$0.47
Dividend Yield1.38%
Ex-Dividend DateDec 31, 2025
Payout FrequencyAnnual
Payout Ratio39.48%
Volume33,301
Open34.06
Previous Close34.18
Day's Range33.68 - 34.22
52-Week Low22.91
52-Week High41.50
Beta1.48
Holdings52
Inception DateApr 9, 2015

About FFTY

Fund Home Page

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 TR index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is issued by Innovator.

Asset Class Equity
Category Mid-Cap Growth
Region North America
Stock Exchange NYSEARCA
Ticker Symbol FFTY
ETF Provider Innovator
Index Tracked IBD 50 TR

Top 10 Holdings

34.83% of assets
NameSymbolWeight
Aura Minerals Inc.ORA3.70%
FabrinetFN3.60%
Argan, Inc.AGX3.56%
Comfort Systems USA, Inc.FIX3.52%
Vertiv Holdings CoVRT3.50%
Kiniksa Pharmaceuticals International, plcKNSA3.49%
Everus Construction Group, Inc.ECG3.46%
Okeanis Eco Tankers Corp.ECO3.44%
Modine Manufacturing CompanyMOD3.36%
Lumentum Holdings Inc.LITE3.19%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 31, 2025$0.46895Jan 2, 2026
Dec 31, 2024$0.25908Jan 2, 2025
Dec 28, 2023$0.15529Jan 2, 2024
Oct 26, 2023$0.00214Oct 30, 2023
Dec 29, 2022$0.60033Jan 3, 2023
Dec 30, 2021$0.09915Jan 3, 2022
Full Dividend History

Performance

FFTY had a total return of 41.24% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.31%.

News

Franklin Custodian Funds' Dynatech Fund: Don't Buy This Dip – Legacy Fund Ratings Are Misleading

A deep dive into this fund's holdings reveal a portfolio that is inferior to its benchmark and the S&P 500.

Other symbols: VFMO
4 years ago - Forbes